Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 721 to 732 of 733 entries
Sorted by: Best Match Show Resources per page
Increased availability of drugs is correlated with the number of patients diagnosed thereafter: Data analysis of 45 intractable diseases.

Journal of clinical pharmacy and therapeutics

Oka T, Narukawa M.
PMID: 33959993
J Clin Pharm Ther. 2021 Oct;46(5):1319-1325. doi: 10.1111/jcpt.13434. Epub 2021 May 07.

WHAT IS KNOWN: Estimates of the prevalence of diseases can be affected by non-biological factors such as change in diagnostic criteria and change in awareness of the diseases. The launch of a new drug is a potential contributory factor...

Cite
Oka T, Narukawa M. Increased availability of drugs is correlated with the number of patients diagnosed thereafter: Data analysis of 45 intractable diseases. J Clin Pharm Ther. 2021;46(5):1319-1325doi: 10.1111/jcpt.13434.
Oka, T., & Narukawa, M. (2021). Increased availability of drugs is correlated with the number of patients diagnosed thereafter: Data analysis of 45 intractable diseases. Journal of clinical pharmacy and therapeutics, 46(5), 1319-1325. https://doi.org/10.1111/jcpt.13434
Oka, Toshiya, and Narukawa, Mamoru. "Increased availability of drugs is correlated with the number of patients diagnosed thereafter: Data analysis of 45 intractable diseases." Journal of clinical pharmacy and therapeutics vol. 46,5 (2021): 1319-1325. doi: https://doi.org/10.1111/jcpt.13434
Oka T, Narukawa M. Increased availability of drugs is correlated with the number of patients diagnosed thereafter: Data analysis of 45 intractable diseases. J Clin Pharm Ther. 2021 Oct;46(5):1319-1325. doi: 10.1111/jcpt.13434. Epub 2021 May 07. PMID: 33959993.
Copy Download .nbib Format: NLM
Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database.

Journal of clinical pharmacy and therapeutics

Zhou Z, Wang C, Ying L, Jin M, Zhang F, Shi D.
PMID: 33768534
J Clin Pharm Ther. 2021 Aug;46(4):1148-1154. doi: 10.1111/jcpt.13404. Epub 2021 Mar 25.

WHAT IS KNOWN AND OBJECTIVE: Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors (ALK TKIs) are standard first-line therapy for non-small cell lung cancer patients with ALK rearrangement. Although some cases of hepatotoxicity related to these drugs have been reported, there...

Cite
Zhou Z, Wang C, Ying L, et al. Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database. J Clin Pharm Ther. 2021;46(4):1148-1154doi: 10.1111/jcpt.13404.
Zhou, Z., Wang, C., Ying, L., Jin, M., Zhang, F., & Shi, D. (2021). Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database. Journal of clinical pharmacy and therapeutics, 46(4), 1148-1154. https://doi.org/10.1111/jcpt.13404
Zhou, Ziye, et al. "Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database." Journal of clinical pharmacy and therapeutics vol. 46,4 (2021): 1148-1154. doi: https://doi.org/10.1111/jcpt.13404
Zhou Z, Wang C, Ying L, Jin M, Zhang F, Shi D. Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database. J Clin Pharm Ther. 2021 Aug;46(4):1148-1154. doi: 10.1111/jcpt.13404. Epub 2021 Mar 25. PMID: 33768534.
Copy Download .nbib Format: NLM
Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.

Journal of clinical pharmacy and therapeutics

Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT.
PMID: 34254331
J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12.

WHAT IS KNOWN AND OBJECTIVES: Migraine is a disabling disorder that affects individuals of all ages. To date, there are multiple limitations to using guidelines-recommended treatments and preventive therapies. The goal of this review was to provide a comprehensive...

Cite
Omaer A, Aldosari FM, McGlamery E, et al. Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13445.
Omaer, A., Aldosari, F. M., McGlamery, E., Alrashed, S., Wool, S., & Fazel, M. T. (2021). Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13445
Omaer, Abubker, et al. "Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13445
Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT. Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12. PMID: 34254331.
Copy Download .nbib Format: NLM
How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios.

Journal of clinical pharmacy and therapeutics

Isah A, Adibe MO, Abba A, Dim OF, Ekwuofu AA, Ma'aji HU, Ukwe CV, Udeogaranya PO, Okonta MJ.
PMID: 34448210
J Clin Pharm Ther. 2021 Dec;46(6):1695-1705. doi: 10.1111/jcpt.13519. Epub 2021 Aug 27.

WHAT IS KNOWN AND OBJECTIVE: Donor agencies provide most of the funds for HIV services in developing countries. Due to the global economic downturn, there has been a reduction in funding for HIV-related services in Nigeria. This study compared...

Cite
Isah A, Adibe MO, Abba A, et al. How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios. J Clin Pharm Ther. 2021;46(6):1695-1705doi: 10.1111/jcpt.13519.
Isah, A., Adibe, M. O., Abba, A., Dim, O. F., Ekwuofu, A. A., Ma'aji, H. U., Ukwe, C. V., Udeogaranya, P. O., & Okonta, M. J. (2021). How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios. Journal of clinical pharmacy and therapeutics, 46(6), 1695-1705. https://doi.org/10.1111/jcpt.13519
Isah, Abdulmuminu, et al. "How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios." Journal of clinical pharmacy and therapeutics vol. 46,6 (2021): 1695-1705. doi: https://doi.org/10.1111/jcpt.13519
Isah A, Adibe MO, Abba A, Dim OF, Ekwuofu AA, Ma'aji HU, Ukwe CV, Udeogaranya PO, Okonta MJ. How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios. J Clin Pharm Ther. 2021 Dec;46(6):1695-1705. doi: 10.1111/jcpt.13519. Epub 2021 Aug 27. PMID: 34448210.
Copy Download .nbib Format: NLM
Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.

Journal of clinical pharmacy and therapeutics

[No authors listed]
PMID: 34254331
J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12.

Retraction: Abubker Omaer, Fahad M. Aldosari, Emily McGlamery, Saad Alrashed, Steven Wool, Maryam T. Fazel, Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information, Journal of Clinical Pharmacy and Therapeutics 2021; 00: 1-8 (https://doi.org/10.1111/jcpt.13445)....

Cite
Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13445.
(2021). Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13445
"Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13445
Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12. PMID: 34254331.
Copy Download .nbib Format: NLM
The effect of dexmedetomidine on renal function after surgery: A systematic review and meta-analysis.

Journal of clinical pharmacy and therapeutics

Loomba RS, Villarreal EG, Dhargalkar J, Rausa J, Dorsey V, Farias JS, Flores S.
PMID: 34510502
J Clin Pharm Ther. 2021 Sep 12; doi: 10.1111/jcpt.13527. Epub 2021 Sep 12.

WHAT IS KNOWN AND OBJECTIVE: Acute kidney injury (AKI) is a complication following surgery and has been associated with worsened patient outcomes. Providers have used agents that may confer a degree of renal protection in the perioperative stage. Such...

Cite
Loomba RS, Villarreal EG, Dhargalkar J, et al. The effect of dexmedetomidine on renal function after surgery: A systematic review and meta-analysis. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13527.
Loomba, R. S., Villarreal, E. G., Dhargalkar, J., Rausa, J., Dorsey, V., Farias, J. S., & Flores, S. (2021). The effect of dexmedetomidine on renal function after surgery: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13527
Loomba, Rohit S, et al. "The effect of dexmedetomidine on renal function after surgery: A systematic review and meta-analysis." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13527
Loomba RS, Villarreal EG, Dhargalkar J, Rausa J, Dorsey V, Farias JS, Flores S. The effect of dexmedetomidine on renal function after surgery: A systematic review and meta-analysis. J Clin Pharm Ther. 2021 Sep 12; doi: 10.1111/jcpt.13527. Epub 2021 Sep 12. PMID: 34510502.
Copy Download .nbib Format: NLM
Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose.

Journal of clinical pharmacy and therapeutics

Pergolizzi JV, Webster LR, Vortsman E, Ann LeQuang J, Raffa RB.
PMID: 34240442
J Clin Pharm Ther. 2021 Dec;46(6):1505-1508. doi: 10.1111/jcpt.13484. Epub 2021 Jul 08.

WHAT IS KNOWN AND OBJECTIVE: A large percentage of opioid overdose fatalities involve fentanyl or one of its legal or illegal analogs (F/FAs). Is there something about the pharmacology of these drugs that make them unusually dangerous in an...

Cite
Pergolizzi JV, Webster LR, Vortsman E, et al. Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose. J Clin Pharm Ther. 2021;46(6):1505-1508doi: 10.1111/jcpt.13484.
Pergolizzi, J. V., Webster, L. R., Vortsman, E., Ann LeQuang, J., & Raffa, R. B. (2021). Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose. Journal of clinical pharmacy and therapeutics, 46(6), 1505-1508. https://doi.org/10.1111/jcpt.13484
Pergolizzi, Joseph V, et al. "Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose." Journal of clinical pharmacy and therapeutics vol. 46,6 (2021): 1505-1508. doi: https://doi.org/10.1111/jcpt.13484
Pergolizzi JV, Webster LR, Vortsman E, Ann LeQuang J, Raffa RB. Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose. J Clin Pharm Ther. 2021 Dec;46(6):1505-1508. doi: 10.1111/jcpt.13484. Epub 2021 Jul 08. PMID: 34240442.
Copy Download .nbib Format: NLM
Fingerprint loss during combination therapy using osimertinib and anlotinib: A case report.

Journal of clinical pharmacy and therapeutics

Xie L, Feng Y, Sun J.
PMID: 34240438
J Clin Pharm Ther. 2021 Jul 08; doi: 10.1111/jcpt.13480. Epub 2021 Jul 08.

WHAT IS KNOWN AND OBJECTIVE: Recent studies prove that epidermal growth factor receptor (EGFR) inhibitors combined with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) are more effective than EGFR TKI monotherapy for treatment of EGFR-mutated advanced...

Cite
Xie L, Feng Y, Sun J. Fingerprint loss during combination therapy using osimertinib and anlotinib: A case report. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13480.
Xie, L., Feng, Y., & Sun, J. (2021). Fingerprint loss during combination therapy using osimertinib and anlotinib: A case report. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13480
Xie, Lijiao, et al. "Fingerprint loss during combination therapy using osimertinib and anlotinib: A case report." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13480
Xie L, Feng Y, Sun J. Fingerprint loss during combination therapy using osimertinib and anlotinib: A case report. J Clin Pharm Ther. 2021 Jul 08; doi: 10.1111/jcpt.13480. Epub 2021 Jul 08. PMID: 34240438.
Copy Download .nbib Format: NLM
Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review.

Journal of clinical pharmacy and therapeutics

Farhat A, Al-Hajje A, Csajka C, Panchaud A.
PMID: 33765352
J Clin Pharm Ther. 2021 Aug;46(4):877-886. doi: 10.1111/jcpt.13408. Epub 2021 Mar 25.

WHAT IS KNOWN AND OBJECTIVE: Many explicit tools have been developed to reduce prescribing errors and ensure patients' safety. The impact of explicit tools is not well studied. The objective of this study was (a) to conduct a systematic...

Cite
Farhat A, Al-Hajje A, Csajka C, et al. Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review. J Clin Pharm Ther. 2021;46(4):877-886doi: 10.1111/jcpt.13408.
Farhat, A., Al-Hajje, A., Csajka, C., & Panchaud, A. (2021). Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review. Journal of clinical pharmacy and therapeutics, 46(4), 877-886. https://doi.org/10.1111/jcpt.13408
Farhat, Akram, et al. "Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review." Journal of clinical pharmacy and therapeutics vol. 46,4 (2021): 877-886. doi: https://doi.org/10.1111/jcpt.13408
Farhat A, Al-Hajje A, Csajka C, Panchaud A. Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review. J Clin Pharm Ther. 2021 Aug;46(4):877-886. doi: 10.1111/jcpt.13408. Epub 2021 Mar 25. PMID: 33765352.
Copy Download .nbib Format: NLM
Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.

Journal of clinical pharmacy and therapeutics

Jing Y, Kong Y, Hou X, Liu H, Fu Q, Jiao Z, Peng H, Wei X.
PMID: 33768546
J Clin Pharm Ther. 2021 Aug;46(4):1117-1128. doi: 10.1111/jcpt.13407. Epub 2021 Mar 25.

WHAT IS KNOWN AND OBJECTIVES: Tacrolimus (TAC) is a first-line immunosuppressant which is used to prevent transplant rejection after solid organ transplantation (SOT). However, it has a narrow therapeutic index and high individual variability in pharmacokinetics (PK) and pharmacogenomics...

Cite
Jing Y, Kong Y, Hou X, et al. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. J Clin Pharm Ther. 2021;46(4):1117-1128doi: 10.1111/jcpt.13407.
Jing, Y., Kong, Y., Hou, X., Liu, H., Fu, Q., Jiao, Z., Peng, H., & Wei, X. (2021). Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. Journal of clinical pharmacy and therapeutics, 46(4), 1117-1128. https://doi.org/10.1111/jcpt.13407
Jing, Yan, et al. "Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients." Journal of clinical pharmacy and therapeutics vol. 46,4 (2021): 1117-1128. doi: https://doi.org/10.1111/jcpt.13407
Jing Y, Kong Y, Hou X, Liu H, Fu Q, Jiao Z, Peng H, Wei X. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. J Clin Pharm Ther. 2021 Aug;46(4):1117-1128. doi: 10.1111/jcpt.13407. Epub 2021 Mar 25. PMID: 33768546.
Copy Download .nbib Format: NLM
Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.

Journal of clinical pharmacy and therapeutics

Joseph K, Ramireddy K, Madison G, Turco T, Lui M.
PMID: 33768555
J Clin Pharm Ther. 2021 Aug;46(4):1103-1108. doi: 10.1111/jcpt.13409. Epub 2021 Mar 25.

WHAT IS KNOWN AND OBJECTIVE: Vancomycin, an antibiotic commonly used to treat MRSA infections, can be nephrotoxic. Administering vancomycin requires close monitoring of serum vancomycin levels and appropriate dosing based on patients' renal function, underlying infection type and serum...

Cite
Joseph K, Ramireddy K, Madison G, et al. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital. J Clin Pharm Ther. 2021;46(4):1103-1108doi: 10.1111/jcpt.13409.
Joseph, K., Ramireddy, K., Madison, G., Turco, T., & Lui, M. (2021). Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital. Journal of clinical pharmacy and therapeutics, 46(4), 1103-1108. https://doi.org/10.1111/jcpt.13409
Joseph, Keerthy, et al. "Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital." Journal of clinical pharmacy and therapeutics vol. 46,4 (2021): 1103-1108. doi: https://doi.org/10.1111/jcpt.13409
Joseph K, Ramireddy K, Madison G, Turco T, Lui M. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital. J Clin Pharm Ther. 2021 Aug;46(4):1103-1108. doi: 10.1111/jcpt.13409. Epub 2021 Mar 25. PMID: 33768555.
Copy Download .nbib Format: NLM
The impact of an electronic hospital system on therapeutic drug monitoring.

Journal of clinical pharmacy and therapeutics

Firman P, Whitfield K, Tan KS, Clavarino A, Hay K.
PMID: 34328229
J Clin Pharm Ther. 2021 Dec;46(6):1613-1621. doi: 10.1111/jcpt.13497. Epub 2021 Jul 30.

WHAT IS KNOWN AND OBJECTIVE: Australian hospitals have undergone a transformation with both a review and expansion of traditional roles of healthcare professionals and the implementation of an ieMR. The implementation of an ieMR brings large scale organizational change...

Cite
Firman P, Whitfield K, Tan KS, et al. The impact of an electronic hospital system on therapeutic drug monitoring. J Clin Pharm Ther. 2021;46(6):1613-1621doi: 10.1111/jcpt.13497.
Firman, P., Whitfield, K., Tan, K. S., Clavarino, A., & Hay, K. (2021). The impact of an electronic hospital system on therapeutic drug monitoring. Journal of clinical pharmacy and therapeutics, 46(6), 1613-1621. https://doi.org/10.1111/jcpt.13497
Firman, Paul, et al. "The impact of an electronic hospital system on therapeutic drug monitoring." Journal of clinical pharmacy and therapeutics vol. 46,6 (2021): 1613-1621. doi: https://doi.org/10.1111/jcpt.13497
Firman P, Whitfield K, Tan KS, Clavarino A, Hay K. The impact of an electronic hospital system on therapeutic drug monitoring. J Clin Pharm Ther. 2021 Dec;46(6):1613-1621. doi: 10.1111/jcpt.13497. Epub 2021 Jul 30. PMID: 34328229.
Copy Download .nbib Format: NLM
Showing 721 to 732 of 733 entries